Sign in

CIK 0000926617

  • Non-accelerated filer
  • Smaller reporting company

Aspira Women's Health Inc.

Sign in to watch
Ticker
AWHL
Exchange
OTC
Industry
In Vitro & In Vivo Diagnostic Substances
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
330595156
Phone
+1 512-519-0400
Business address
12117 BEE CAVES ROAD BUILDING THREE, SUITE 100, AUSTIN, TX, 78738
Former names
VERMILLION, INC., CIPHERGEN BIOSYSTEMS INC
  1. 4 Grant or award Director acquired 35,909 shares (grant or award)
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Grant or award Director acquired 30,000 shares (grant or award)
  5. 4 Grant or award Director acquired 47,403 shares (grant or award)
  6. 4 Grant or award Director acquired 30,909 shares (grant or award)
  7. 4 Grant or award Director acquired 31,818 shares (grant or award)
  8. 4 Grant or award Director acquired 49,545 shares (grant or award)
  9. 4 Open-market buy 10% owner bought 1,493 shares at $1.60 ($2,389)
  10. 4 Open-market buy 10% owner bought 2,450 shares at an average $1.59 ($3,903)
  11. 4 Open-market buy 10% owner bought 3,700 shares at an average $1.57 ($5,805)
  12. 4 Open-market buy 10% owner bought 30,700 shares at an average $1.46 ($44,748)
  13. 4 Open-market buy 10% owner bought 66,149 shares at an average $1.46 ($96,840)
  14. 4 Open-market buy 10% owner bought 255,100 shares at $1.96 ($499,996)
  15. 4 Open-market buy 10% owner bought 765,308 shares at $1.96 ($1,500,004)
  16. 4 Open-market buy 10% owner bought 512,043 shares at an average $1.96 ($1,003,504)
  17. 4 Grant or award Director acquired 27,711 shares (grant or award)
  18. 4 Grant or award Director acquired 36,082 shares (grant or award)
  19. 4 Grant or award Director acquired 26,340 shares (grant or award)
  20. 4 Grant or award Director acquired 28,091 shares (grant or award)

Page 15 of 28 · 551 filings